Sign in

CIK 0001962011 · <br>Emerging growth company

Kairos Pharma, LTD.

Sign in to watch
Ticker
KAPA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
462993314
Phone
818-404-5541
Business address
2355 WESTWOOD BLVD. #139, LOS ANGELES, CA, 90064
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-10-08 Bhowmick Neil Chief Scientific Officer Grant or award +171,756 1,311,739
2025-10-08 Bae Hyun W. Director Grant or award +19,084 73,370
2025-10-08 Murali Ramachandran VP of Research and Development Grant or award +152,672 299,529
2025-10-08 Keyoung Hansoo Michael Director Grant or award +19,084 29,084
2025-10-08 Singhvi Rahul Director Grant or award +19,084 49,204
2025-10-08 Samuelson Doug Chief Financial Officer Grant or award +152,672 293,039
2025-10-08 Yu John S CEO and Chairman Grant or award +190,840 230,105
2025-09-16 Bae Hyun W. Director Grant or award +10,000 54,286
2025-09-16 Keyoung Hansoo Michael Director Grant or award +10,000 10,000
2025-01-01 Bhowmick Neil Chief Scientific Officer Grant or award +14,000 1,139,983
2025-01-01 Murali Ramachandran VP of Research and Development Grant or award +14,000 147,057
2025-01-01 Yu John S CEO and Chairman Grant or award +14,000 5,355,838
2024-11-25 Murali Ramachandran VP of Research and Development Purchase +200 $1.59 $318 133,057
2024-11-22 Samuelson Doug Chief Financial Officer Purchase +2,500 $1.50 $4K 60,796
2024-11-20 Yu John S CEO and Chairman Purchase +4,000 $1.44 $6K 5,341,837

Page 1 of 1 · 15 trades